Does Argus HQ track new FDA actions for Nova Biomedical Corporation automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Nova Biomedical Corporation is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for Nova Biomedical Corporation?

5 total: 0 warning letters, 5 recalls, 0 approval records, and 0 Form 483 inspection citations.

What is the most recent FDA action on file for Nova Biomedical Corporation?

September 23, 2026. Argus HQ ingests new FDA enforcement records daily.

Has Nova Biomedical Corporation had product recalls?

Yes, 5 recalls on file. See the full history below for each one.

Nova Biomedical Corporation — FDA Compliance Timeline

Argus HQ has recorded 5 FDA events for Nova Biomedical Corporation: 0 warning letters, 5 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2026-09-23 to 2026-09-23. The most severe rating Argus HQ has assigned across this history is "critical". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

FDA action counts

Total FDA actions	5
Warning letters	0
Recalls	5
Approval records	0
Form 483 inspection citations	0
Most recent action	September 23, 2026

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Nova Biomedical Corporation has 5 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-09-23, Argus HQ recorded an FDA recall for Nova Biomedical Corporation, rated "critical" severity in Argus HQ's classification: Nova Biomedical Corporation — Class I recall: StatStrip Glucose Hospital Meter System. Model No: 66739. Glucose test system.. On 2026-09-23, Argus HQ recorded an FDA recall for Nova Biomedical Corporation, rated "critical" severity in Argus HQ's classification: Nova Biomedical Corporation — Class I recall: StatStrip Glucose and B- Ketone meter. Model No: 63910. Glucose test system.. On 2026-09-23, Argus HQ recorded an FDA recall for Nova Biomedical Corporation, rated "critical" severity in Argus HQ's classification: Nova Biomedical Corporation — Class I recall: StatStrip Glucose and B- Ketone meter. Model No: 66429. Glucose test system.. On 2026-09-23, Argus HQ recorded an FDA recall for Nova Biomedical Corporation, rated "critical" severity in Argus HQ's classification: Nova Biomedical Corporation — Class I recall: StatStrip Glucose and B- Ketone meter. Model No: 63683. Glucose test system.. On 2026-09-23, Argus HQ recorded an FDA recall for Nova Biomedical Corporation, rated "critical" severity in Argus HQ's classification: Nova Biomedical Corporation — Class I recall: StatStrip Glucose Hospital Meter System. Model No: 63685. Glucose test system.. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

Does Argus HQ track new FDA actions for Nova Biomedical Corporation automatically?: Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to Nova Biomedical Corporation is observed, this page's event count and history update automatically.
How many FDA actions does Argus HQ track for Nova Biomedical Corporation?: 5 total: 0 warning letters, 5 recalls, 0 approval records, and 0 Form 483 inspection citations.
What is the most recent FDA action on file for Nova Biomedical Corporation?: September 23, 2026. Argus HQ ingests new FDA enforcement records daily.
Has Nova Biomedical Corporation had product recalls?: Yes, 5 recalls on file. See the full history below for each one.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Sep 23, 2026

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Nova Biomedical Corporation — FDA Compliance Timeline. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/company/nova-biomedical-corporation

MLA

"Nova Biomedical Corporation — FDA Compliance Timeline." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/company/nova-biomedical-corporation.

Chicago

Argus HQ Research. "Nova Biomedical Corporation — FDA Compliance Timeline." Digital Empire Holdings LLC. Accessed September 29, 2026. https://argushq.ai/company/nova-biomedical-corporation.

BibTeX

@misc{argushq_argushq_ai_company_nova_biomedical_corporation_2026,
  title = {Nova Biomedical Corporation — FDA Compliance Timeline},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/company/nova-biomedical-corporation},
  note = {Accessed: September 29, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗